A business in context
DHR research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-08-21 | Blair Rainer | S · Sale | Common Stock | 11307.0 | 217.77 |
| 2026-08-21 | Blair Rainer | S · Sale | Common Stock | 7755.0 | 219.35 |
| 2026-08-21 | Blair Rainer | S · Sale | Common Stock | 39193.0 | 218.73 |
| 2026-08-04 | RALES MITCHELL P | A · Grant / award | Common Stock, par value $.01 | 500000.0 | 0.0 |
| 2026-08-04 | RALES MITCHELL P | A · Grant / award | Stock option (right to buy) | 1000000.0 | 0.0 |
| 2026-08-04 | RALES STEVEN M | A · Grant / award | Common Stock, par value $.01 | 500000.0 | 0.0 |
| 2026-08-04 | RALES STEVEN M | A · Grant / award | Stock option (right to buy) | 1000000.0 | 0.0 |
| 2026-08-04 | Riley Christopher Paul | A · Grant / award | Common Stock | 41072.0 | 0.0 |
| 2026-08-04 | Gugino Matthew E | A · Grant / award | Employee stock option (right to buy) | 153563.0 | 0.0 |
| 2026-08-04 | Gutierrez-Ramos Jose-Carlos | A · Grant / award | Common Stock | 13477.0 | 0.0 |
| 2026-08-04 | Milosevich Gregory M | A · Grant / award | Common Stock | 15402.0 | 0.0 |
| 2026-08-04 | Leiken Jonathan | A · Grant / award | Employee stock option (right to buy) | 92138.0 | 0.0 |
| 2026-08-04 | Sawyer Montgomery Julie A | A · Grant / award | Employee stock option (right to buy) | 245701.0 | 0.0 |
| 2026-08-04 | Bouda Christopher | A · Grant / award | Employee stock option (right to buy) | 12286.0 | 0.0 |
| 2026-07-31 | FILLER LINDA | A · Grant / award | Phantom shares | 18.33 | 194.98 |
| 2026-07-31 | Zerhouni Elias A. | A · Grant / award | Phantom shares | 236.63 | 194.98 |
| 2026-07-31 | SPOON ALAN G | A · Grant / award | Phantom shares | 229.9 | 194.98 |
| 2026-07-31 | List Teri | A · Grant / award | Phantom shares | 15.72 | 194.98 |
| 2026-07-31 | Sanders A Shane | A · Grant / award | Phantom shares | 211.21 | 194.98 |
| 2026-07-31 | Dewan Feroz | A · Grant / award | Phantom shares | 171.2 | 194.98 |
| 2026-07-31 | Stevens Raymond C | A · Grant / award | Phantom shares | 181.55 | 194.98 |
| 2026-07-15 | Bouda Christopher | F · Tax / exercise payment | Common Stock | 60.0 | 200.79 |
| 2026-07-15 | FILLER LINDA | F · Tax / exercise payment | Common Stock | 1181.0 | 200.79 |
| 2026-07-15 | FILLER LINDA | M · Exercise / conversion | Common Stock | 3298.0 | 71.88 |
| 2026-07-15 | FILLER LINDA | M · Exercise / conversion | Director stock option (right to buy) | 3298.0 | 0.0 |
| 2026-07-15 | Zerhouni Elias A. | F · Tax / exercise payment | Common Stock | 1181.0 | 200.79 |
| 2026-07-15 | Zerhouni Elias A. | M · Exercise / conversion | Common Stock | 3298.0 | 71.88 |
| 2026-07-15 | Zerhouni Elias A. | M · Exercise / conversion | Director stock option (right to buy) | 3298.0 | 0.0 |
Identity & relationships
SEC issuer · 0000313616DANAHER CORP /DE/
Danaher (United Kingdom)Danaher (China)Danaher (Australia)Danaher (Sweden)Danaher (Germany)Danaher (Singapore)Danaher (Switzerland)Beckman CoulterNobel BiocareIntegrated DNA Technologies
- Legal Entity Identifier
- S4BKK9OTCEWQ3YHPFM11
- GLEIF legal name
- DANAHER CORPORATION
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2025-12-26T05:35:40Z
Search names and former names
View Wikidata identity and references ↗
- Danaher Corporation · alias · wikidata
- Danaher · alias · wikidata
- Danaher (United Kingdom) · subsidiary · wikidata
- Danaher (China) · subsidiary · wikidata
- Danaher (Australia) · subsidiary · wikidata
- Danaher (Sweden) · subsidiary · wikidata
- Danaher (Germany) · subsidiary · wikidata
- Danaher (Singapore) · subsidiary · wikidata
- Danaher (Switzerland) · subsidiary · wikidata
- Beckman Coulter · subsidiary · wikidata
- Beckman Instruments · subsidiary · wikidata
- Beckman Instruments, Inc. · subsidiary · wikidata
- Nobel Biocare · subsidiary · wikidata
- Integrated DNA Technologies · subsidiary · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $23.88B | $25.64B |
| 2023-12-31 | $23.89B | $26.42B |
| 2022-12-31 | $26.64B | $30.67B |
| 2021-12-31 | $24.80B | $30.84B |
| 2020-12-31 | $22.28B | $29.01B |
| 2019-12-31 | $17.91B | $23.60B |
| 2018-12-31 | $17.05B | $22.88B |
| 2017-12-31 | $15.52B | $21.33B |